Banking on biomarkers – improving the diagnosis of early stage NSCLC
Banking on biomarkers – improving the diagnosis of early stage NSCLC
How can a systems biology approach aid precision cancer medicine?
Personalised, genomic-guided combination therapy could transform early disease management in ovarian and breast cancer
What can T-cells see on human cancer?
Moving precision medicine for lung cancer into the adjuvant setting
WIN Symposium 2015 highlights
Next generation of trials with targeted agents
The importance of target expression in personalised medicine
Radiation and immunology – a new therapeutic partnership
Meta-analysis confirms benefits and safety of precision medicine
TargomiRs show promise in phase I study of malignant mesothelioma
SPECTAlung: improving clinical trial access for patients with thoracic tumours